UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Ardelyx
ARDX
$1.24B
| $495K | ﹤0.01% |
74,800
+13,800
| +23% | +$94.7K |
|
2327
KRONOS Worldwide
KRO
$712M
| $495K | ﹤0.01% |
32,347
| – | – |
|
|
CIVI
2328
DELISTED
Civitas Resources
CIVI
| $495K | ﹤0.01% |
13,847
+3,384
| +32% | +$95.4K |
|
|
VRAY
2329
DELISTED
ViewRay, Inc.
VRAY
| $494K | ﹤0.01% |
113,448
| – | – |
|
|
REVG
2330
DELISTED
REV Group
REVG
| $493K | ﹤0.01% |
25,744
+14,905
| +138% | +$197K |
|
|
THR
2331
DELISTED
Thermon Group Holdings
THR
| $492K | ﹤0.01% |
25,222
| – | – |
|
2332
Victory Capital Holdings
VCTR
$6.09B
| $491K | ﹤0.01% |
19,200
| – | – |
|
2333
Warner Music
WMG
$15.2B
| $490K | ﹤0.01% |
+14,285
| New | +$511K |
|
2334
Ranpak Holdings
PACK
$500M
| $487K | ﹤0.01% |
24,300
+5,000
| +26% | +$93.1K |
|
|
ISEE
2335
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $487K | ﹤0.01% |
78,851
+21,451
| +37% | +$130K |
|
2336
Standard BioTools
LAB
$342M
| $483K | ﹤0.01% |
106,900
-8,400
| -7% | -$46.1K |
|
|
DHIL
2337
DELISTED
Diamond Hill
DHIL
| $482K | ﹤0.01% |
3,092
-782
| -20% | -$120K |
|
|
NFBK
2338
DELISTED
Northfield Bancorp
NFBK
| $482K | ﹤0.01% |
30,282
| – | – |
|
|
BFX
2339
DELISTED
BowFlex Inc.
BFX
| $480K | ﹤0.01% |
30,684
-7,069
| -19% | -$152K |
|
2340
Precision BioSciences
DTIL
$178M
| $478K | ﹤0.01% |
1,540
+413
| +37% | +$145K |
|
2341
John B. Sanfilippo & Son
JBSS
$986M
| $476K | ﹤0.01% |
5,271
| – | – |
|
2342
Nabors Industries
NBR
$1.17B
| $476K | ﹤0.01% |
5,092
| – | – |
|
2343
Kodak
KODK
$809M
| $475K | ﹤0.01% |
60,400
+6,800
| +13% | +$62K |
|
2344
Replimune Group
REPL
$454M
| $475K | ﹤0.01% |
15,580
-1,120
| -7% | -$41.9K |
|
|
VBIV
2345
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $474K | ﹤0.01% |
5,085
-7
| -0.1% | -$710 |
|
|
HSII
2346
DELISTED
Heidrick & Struggles
HSII
| $470K | ﹤0.01% |
13,169
+5,627
| +75% | +$191K |
|
|
FRTA
2347
DELISTED
Forterra, Inc
FRTA
| $465K | ﹤0.01% |
19,998
+7,438
| +59% | +$160K |
|
2348
Napco Security Technologies
NSSC
$1.3B
| $456K | ﹤0.01% |
+26,200
| New | +$404K |
|
2349
Vanguard Small-Cap Value ETF
VBR
$37.2B
| $454K | ﹤0.01% |
3,189
| – | – |
|
2350
Artivion
AORT
$1.34B
| $452K | ﹤0.01% |
20,021
-12,527
| -38% | -$306K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.